JP2023528310A5 - - Google Patents
Info
- Publication number
- JP2023528310A5 JP2023528310A5 JP2022572365A JP2022572365A JP2023528310A5 JP 2023528310 A5 JP2023528310 A5 JP 2023528310A5 JP 2022572365 A JP2022572365 A JP 2022572365A JP 2022572365 A JP2022572365 A JP 2022572365A JP 2023528310 A5 JP2023528310 A5 JP 2023528310A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- trifluoromethyl
- phenyl
- benzamide
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20176360.4 | 2020-05-25 | ||
| EP20176360 | 2020-05-25 | ||
| PCT/EP2021/063738 WO2021239643A1 (en) | 2020-05-25 | 2021-05-24 | Benzylamine derivatives as ddrs inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023528310A JP2023528310A (ja) | 2023-07-04 |
| JP2023528310A5 true JP2023528310A5 (enExample) | 2024-05-30 |
| JP7761595B2 JP7761595B2 (ja) | 2025-10-28 |
Family
ID=70847297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022572365A Active JP7761595B2 (ja) | 2020-05-25 | 2021-05-24 | Ｄｄｒ阻害物質としてのベンジルアミン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230227447A1 (enExample) |
| EP (1) | EP4157447A1 (enExample) |
| JP (1) | JP7761595B2 (enExample) |
| KR (1) | KR20230016190A (enExample) |
| CN (1) | CN115697485B (enExample) |
| AU (1) | AU2021282320A1 (enExample) |
| BR (1) | BR112022022679A2 (enExample) |
| CA (1) | CA3178242A1 (enExample) |
| MX (1) | MX2022014295A (enExample) |
| WO (1) | WO2021239643A1 (enExample) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050091462A (ko) | 2004-03-12 | 2005-09-15 | 한국과학기술연구원 | 푸로피리미딘 화합물 및 이를 포함하는 ｄｄｒ2 티로신키나아제 활성 저해제 |
| US7754717B2 (en) * | 2005-08-15 | 2010-07-13 | Amgen Inc. | Bis-aryl amide compounds and methods of use |
| LT2848610T (lt) * | 2006-11-15 | 2017-11-10 | Ym Biosciences Australia Pty Ltd | Kinazės aktyvumo inhibitoriai |
| KR101126736B1 (ko) | 2008-11-27 | 2012-04-12 | 주식회사 레고켐 바이오사이언스 | 티로신 키나아제 저해 화합물, 이의 이성질체 또는 이의 약학적으로 허용가능한 염 및 이를 포함하는 약학적 조성물 |
| EP2937345B1 (en) * | 2009-12-29 | 2018-03-21 | Dana-Farber Cancer Institute, Inc. | Type ii raf kinase inhibitors |
| BR112014026266A2 (pt) | 2012-04-24 | 2017-06-27 | Chugai Pharmaceutical Co Ltd | derivado de quinazolidinadiona |
| JP2015530378A (ja) | 2012-08-29 | 2015-10-15 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | 変形性関節症の処置のためのｄｄｒ２インヒビター |
| FR3000493A1 (fr) * | 2012-12-28 | 2014-07-04 | Oribase Pharma | Nouveaux inhibiteurs de proteines kinases |
| WO2015004481A1 (en) | 2013-07-11 | 2015-01-15 | Astex Therapeutics Limited | Imidazo-condensed bicycles as inhibitors of discoidin domain receptors (ddrs) |
| US10005739B2 (en) | 2013-10-23 | 2018-06-26 | Chugai Seiyaku Kabushiki Kaisha | Quinazolinone and isoquinolinone derivative |
| EP3209299A4 (en) | 2014-10-22 | 2018-04-04 | The Board of Regents of The University of Texas System | Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof |
| CN107849044B (zh) | 2015-07-03 | 2021-06-25 | 豪夫迈·罗氏有限公司 | 作为ddr1抑制剂的三氮杂-螺癸酮类化合物 |
| WO2017038870A1 (ja) | 2015-08-31 | 2017-03-09 | 東レ株式会社 | 尿素誘導体及びその用途 |
-
2021
- 2021-05-24 WO PCT/EP2021/063738 patent/WO2021239643A1/en not_active Ceased
- 2021-05-24 BR BR112022022679A patent/BR112022022679A2/pt unknown
- 2021-05-24 EP EP21726678.2A patent/EP4157447A1/en active Pending
- 2021-05-24 CA CA3178242A patent/CA3178242A1/en active Pending
- 2021-05-24 MX MX2022014295A patent/MX2022014295A/es unknown
- 2021-05-24 KR KR1020227043598A patent/KR20230016190A/ko active Pending
- 2021-05-24 AU AU2021282320A patent/AU2021282320A1/en active Pending
- 2021-05-24 JP JP2022572365A patent/JP7761595B2/ja active Active
- 2021-05-24 US US17/927,762 patent/US20230227447A1/en active Pending
- 2021-05-24 CN CN202180037706.3A patent/CN115697485B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7164774B2 (ja) | 置換イミダゾ［１，２－ｂ］ピリダジン、置換イミダゾ［１，５－ｂ］ピリダジン、関連化合物、および医学的障害の治療におけるその使用 | |
| JP4636486B2 (ja) | 脈管形成阻害活性を有するアリール尿素 | |
| IL295487A (en) | gcn2 modulator compounds | |
| JP2017508766A5 (enExample) | ||
| JP2016505529A5 (enExample) | ||
| KR20010050223A (ko) | Ｃｒｆ 길항제 및 관련 조성물의 용도 | |
| JP2014037426A5 (enExample) | ||
| RU2016141645A (ru) | ИНГИБИТОРЫ TrkA КИНАЗЫ, ОСНОВАННЫЕ НА НИХ КОМПОЗИЦИИ И СПОСОБЫ | |
| TWI439464B (zh) | 二胺衍生物之製造方法 | |
| JP2023532257A5 (enExample) | ||
| US9145354B2 (en) | Pharmaceutical compounds | |
| JP2007519694A5 (enExample) | ||
| RS53275B (sr) | Aril-piridin kao inhibitor aldosteron sintaze | |
| CN103906733A (zh) | Trpm8拮抗剂及其在治疗中的用途 | |
| JP2004529926A5 (enExample) | ||
| CN113727972B (zh) | 末端胺基被芳基或杂芳基取代的新的腙衍生物及其用途 | |
| JP7667764B2 (ja) | 線維症疾患の治療及び／又は予防用アミノナフトキノン化合物 | |
| JP2023545452A5 (enExample) | ||
| JP2011516546A5 (enExample) | ||
| RU2025103590A (ru) | Гетероарильные производные в качестве ингибиторов ddr | |
| RU2025138686A (ru) | Гетероарильные производные в качестве ингибиторов ddr | |
| JP2024512070A5 (enExample) | ||
| RU2023127295A (ru) | Производные индолина в качестве ингибиторов ddr | |
| RU2773333C2 (ru) | ЗАМЕЩЕННЫЕ ИМИДАЗО[1,2-b]ПИРИДАЗИНЫ, ЗАМЕЩЕННЫЕ ИМИДАЗО[1,5-b]ПИРИДАЗИНЫ, РОДСТВЕННЫЕ СОЕДИНЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ ПАТОЛОГИЧЕСКИХ СОСТОЯНИЙ | |
| JP2024540916A5 (enExample) |